|
ALDH5A1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.907200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.292400E-01 |
| Normal-vs-Stage2 |
2.835600E-01 |
| Normal-vs-Stage3 |
3.914000E-01 |
| Normal-vs-Stage4 |
2.509400E-01 |
| Stage1-vs-Stage2 |
9.702300E-02 |
| Stage1-vs-Stage3 |
6.816000E-01 |
| Stage1-vs-Stage4 |
4.462200E-01 |
| Stage2-vs-Stage3 |
5.564500E-02 |
| Stage2-vs-Stage4 |
5.672200E-02 |
| Stage3-vs-Stage4 |
6.938400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.926600E-01 |
| Normal-vs-AfricanAmerican |
5.839600E-01 |
| Normal-vs-Asian |
4.173000E-01 |
| Caucasian-vs-AfricanAmerican |
1.564550E-01 |
| Caucasian-vs-Asian |
9.491800E-01 |
| AfricanAmerican-vs-Asian |
2.591200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.362200E-01 |
| Normal-vs-Female |
4.546400E-01 |
| Male-vs-Female |
5.594000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.862200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.656000E-01 |
| Normal-vs-Age(61-80Yrs) |
8.083000E-01 |
| Normal-vs-Age(81-100Yrs) |
8.651600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.787600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.893550E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.745400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.842800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.969400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.237600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.536400E-02 |
| Classical-VS-Follicular |
1.074110E-02 |
| Classical-VS-Other |
3.655600E-01 |
| Classical-VS-Normal |
5.036400E-01 |
| Tall-VS-Follicular |
2.341200E-03 |
| Tall-VS-Other |
7.855800E-01 |
| Tall-VS-Normal |
6.280400E-02 |
| Follicular-VS-Other |
1.311790E-01 |
| Follicular-VS-Normal |
1.955350E-01 |
| Other-VS-Normal |
1.910170E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.015000E-01 |
| Normal-vs-N1 |
1.019840E-01 |
| N0-vs-N1 |
8.923600E-02 |
|
|
